Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-METHYL-6,7,8,9-TETRAHYDRO-5H-CARBAZOLE-3-CARBOXYLIC ACID is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

446829-41-0

Post Buying Request

446829-41-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

446829-41-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 446829-41-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,6,8,2 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 446829-41:
(8*4)+(7*4)+(6*6)+(5*8)+(4*2)+(3*9)+(2*4)+(1*1)=180
180 % 10 = 0
So 446829-41-0 is a valid CAS Registry Number.

446829-41-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-METHYL-6,7,8,9-TETRAHYDRO-5H-CARBAZOLE-3-CARBOXYLIC ACID

1.2 Other means of identification

Product number -
Other names 3-methyl-1,2,3,4-tetrahydro-9H-carbazole-6-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:446829-41-0 SDS

446829-41-0Downstream Products

446829-41-0Relevant articles and documents

HEPATITIS C VIRUS ENTRY INHIBITORS

-

Page/Page column 84, (2010/11/30)

The present invention relates to the use of tricyclic diphenylamine derivative compounds for prevention and/or treatment of Hepatitis C virus (HCV) infection by inhibiting HCV entry into permissive cells.

CARBAZOLE DERIVATIVES FOR TREATING POLYCYSTIC KIDNEY DISEASE

-

Page/Page column 77-78, (2010/10/19)

Compounds represented by Structural Formula (I): where X is -H, -OR, -SH, -OC(O)R, -OC(O)OR,-OC(O)NRR or -SC(O)OR have anti-cystogenic activity, particularly against polycystic kidney disease. Such compounds can be used in pharmaceutical compounds and in

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 446829-41-0